To contact us Click HERE
It is known that the desired shape and position of the nipple-areola
complex may be difficult to achieve in vertical-scar reduction
mammaplasty.
The marking of a mosque-shaped areolar pattern varies from
one surgeon to another, and therefore, periareolar trimming or resection
may be inevitable with the use of such technique. We have developed a
device to standardize the periareolar marking, and reduce the irregularity
of the periareolar region.
This device mimics the elasticity of normal
breast tissue, and has the flexibility to be applicable to all breast
types.
We believe that this device improves the results of vertical-scar
reduction mammaplasty and can eliminate the necessity of "last-minute"
modifications intraoperatively.
For more information visit:
-- cosmedicistanbul
-- springer/medicine/surgery/journal/238
Article published:
Journal European Journal of Plastic Surgery
Publisher Springer Berlin / Heidelberg
ISSN 0930-343X (Print) 1435-0130 (Online)
Category Ideas and Innovations
DOI 10.1007/s00238-008-0320-5
Author:
Mustafa Tercan, Assoc Prof.
Istanbul Turkey
cosmedicistanbul
Friday, April 27, 2012
Skin-Lightening Cremes Sold On Black Market Have Serious Health Risks
To contact us Click HERE
A Clinical Picture described in the February 16, 2008 issue of The
Lancet underlines the perils of using skin lightening creams sold on
the black market. Dr. Tricia Tan and Dr. Tony Goldstone of the
Endrocrine Unit in the Department of Investigative Medicine, Imperial
College Healthcare NHS
Trust, Hammersmith
Hospital, London, UK, were involved in the team that treated the
patients and co-authored this piece.
The woman, at 28 years old, had gained 12.7 kg (28.0 lb) in the
previous three years and had been attempting impregnation for 18 months
unsuccessfully, despite a regular menstrual cycle. She also described
stripes on her arms, back abdomen, and legs, in addition to sensitivity
to bruising and recurrent thrush or yeast infection. Otherwise, her
medical background was not remarkable, and she specifically denied the
use of illegal or prescription drugs.
Doctors noted central obesity (a Body Mass Index (BMI) greater than
36.6 kg/m2, where a BMI that is greater than 30
is considered obese), a pad of fat between her shoulder blades, and
round face. She had pigmented stretch marks on her body, as well as
thin, bruised skin, and mild hair growth on her back and face, combined
with muscle weakness.
Tentatively, a diagnosis of Cushing's syndrome was proposed. Cushing's
syndrome results from excess levels of steroid hormones in the blood,
generally coming from the adrenal glands, and is usually caused by a
directly malfunctioning adrenal gland or an overactive signal from the
pituitary gland to the adrenal glands with the same result. However, in
this patient, blood concentrations of cortisol, a steroid hormone, and
corticotropin, the signaling hormone from the pituitary, were very low.
A second inquiry was made to the patient regarding drugs, and the
patient conceded to using a skin-lightening cream for up to seven years
previous. The source of this cream was not a pharmacy but rather a
local shop, which was not stocking it legally. Deeper investigation
made it clear that the cream had clobetasol, a strong steroid,
and that she had been using two tubes (approximately 60g) per week.
A conclusion was made regarding skin-lightening cremes as they impact
the clinical settting.
"Patients are often reluctant to admit that they
have used skin-lightening creams - especially if these are supplied
illegally.
Similarly, doctors can be unaware of the need to inquire. But the
market is worth millions of
pounds a year, in the UK alone. Creams can contain toxic substances,
such as steroids and
hydroxyquinone - and patients are typically unaware of the risks."
The pursuit of beauty
Maralyn Druce, Anthony P Goldstone, Tricia M M Tan, Karim Meeran
The Lancet, February 16, 2008, Volume 371
Click
Here For Full Text
Written by Anna Sophia McKenney
Lancet underlines the perils of using skin lightening creams sold on
the black market. Dr. Tricia Tan and Dr. Tony Goldstone of the
Endrocrine Unit in the Department of Investigative Medicine, Imperial
College Healthcare NHS
Trust, Hammersmith
Hospital, London, UK, were involved in the team that treated the
patients and co-authored this piece.
The woman, at 28 years old, had gained 12.7 kg (28.0 lb) in the
previous three years and had been attempting impregnation for 18 months
unsuccessfully, despite a regular menstrual cycle. She also described
stripes on her arms, back abdomen, and legs, in addition to sensitivity
to bruising and recurrent thrush or yeast infection. Otherwise, her
medical background was not remarkable, and she specifically denied the
use of illegal or prescription drugs.
Doctors noted central obesity (a Body Mass Index (BMI) greater than
36.6 kg/m2, where a BMI that is greater than 30
is considered obese), a pad of fat between her shoulder blades, and
round face. She had pigmented stretch marks on her body, as well as
thin, bruised skin, and mild hair growth on her back and face, combined
with muscle weakness.
Tentatively, a diagnosis of Cushing's syndrome was proposed. Cushing's
syndrome results from excess levels of steroid hormones in the blood,
generally coming from the adrenal glands, and is usually caused by a
directly malfunctioning adrenal gland or an overactive signal from the
pituitary gland to the adrenal glands with the same result. However, in
this patient, blood concentrations of cortisol, a steroid hormone, and
corticotropin, the signaling hormone from the pituitary, were very low.
A second inquiry was made to the patient regarding drugs, and the
patient conceded to using a skin-lightening cream for up to seven years
previous. The source of this cream was not a pharmacy but rather a
local shop, which was not stocking it legally. Deeper investigation
made it clear that the cream had clobetasol, a strong steroid,
and that she had been using two tubes (approximately 60g) per week.
A conclusion was made regarding skin-lightening cremes as they impact
the clinical settting.
"Patients are often reluctant to admit that they
have used skin-lightening creams - especially if these are supplied
illegally.
Similarly, doctors can be unaware of the need to inquire. But the
market is worth millions of
pounds a year, in the UK alone. Creams can contain toxic substances,
such as steroids and
hydroxyquinone - and patients are typically unaware of the risks."
The pursuit of beauty
Maralyn Druce, Anthony P Goldstone, Tricia M M Tan, Karim Meeran
The Lancet, February 16, 2008, Volume 371
Click
Here For Full Text
Written by Anna Sophia McKenney
News Briefs From Plastic Surgery 2009
To contact us Click HERE
Creating the Youthful Eye - Is Less Really More?
Take a look at the latest issue of Marie Claire and you're sure to notice the fresh-faced beauty with youthful eyes on the cover. Many try to recapture this look through eyelid rejuvenation. However, when it comes to eyelid surgery, is it better to remove or reposition tissue in the upper eyelid? Plastic surgeons at the American Society of Plastic Surgeons (ASPS) Plastic Surgery 2009 conference, Oct. 23-27, in Seattle, are presenting differing perspectives on eyelid rejuvenation, comparing tradition, tried and true, versus novel approaches. The common use of fillers and muscle relaxants (botulinum toxins) around the eye has lead to a serious reconsideration on how to best enhance the appearance of the upper eyelid region.
By the Numbers:
More than 220,000 eyelid surgeries were performed in 2008, making it the fourth most popular procedure, reports the ASPS.
In 2008, more eyelid surgeries were performed in the Mountain and Pacific regions of the U.S., than anywhere else in the country.
Panel: "Rejuvenation of the Upper Eyelid - Is Less Really More" was held Oct. 26 at the Washington State Convention and Trade Center.
But, the Butt Matters!
While most Americans consider the face the most important cosmetic asset they possess, a growing number of people are very concerned about the appearance of their backsides. Buttock rejuvenation is an increasingly popular procedure ... particularly for people who have had massive weight loss. A panel of plastic surgeons will analyze aesthetic and surgical options to buttock rejuvenation ranging from fat grafting to autoaugmentation (using lower back tissue traditionally removed during a butt lift) with the goal of optimizing patient outcomes and preventing complications at the American Society of Plastic Surgeons (ASPS) Plastic Surgery 2009 conference, Oct. 23-27, in Seattle.
By the Numbers:
In 2008, more than 3,500 buttock lifts and 853 buttock implant procedures were performed, reports the ASPS.
Buttock lifts are up 162 percent since 2000.
Panel: "Achieving Predictable Outcomes in Buttock Rejuvenation - Autoaugmentation vs. Fat Injections" was held Oct. 26 at the Washington State Convention and Trade Center.
Take a look at the latest issue of Marie Claire and you're sure to notice the fresh-faced beauty with youthful eyes on the cover. Many try to recapture this look through eyelid rejuvenation. However, when it comes to eyelid surgery, is it better to remove or reposition tissue in the upper eyelid? Plastic surgeons at the American Society of Plastic Surgeons (ASPS) Plastic Surgery 2009 conference, Oct. 23-27, in Seattle, are presenting differing perspectives on eyelid rejuvenation, comparing tradition, tried and true, versus novel approaches. The common use of fillers and muscle relaxants (botulinum toxins) around the eye has lead to a serious reconsideration on how to best enhance the appearance of the upper eyelid region.
By the Numbers:
More than 220,000 eyelid surgeries were performed in 2008, making it the fourth most popular procedure, reports the ASPS.
In 2008, more eyelid surgeries were performed in the Mountain and Pacific regions of the U.S., than anywhere else in the country.
Panel: "Rejuvenation of the Upper Eyelid - Is Less Really More" was held Oct. 26 at the Washington State Convention and Trade Center.
But, the Butt Matters!
While most Americans consider the face the most important cosmetic asset they possess, a growing number of people are very concerned about the appearance of their backsides. Buttock rejuvenation is an increasingly popular procedure ... particularly for people who have had massive weight loss. A panel of plastic surgeons will analyze aesthetic and surgical options to buttock rejuvenation ranging from fat grafting to autoaugmentation (using lower back tissue traditionally removed during a butt lift) with the goal of optimizing patient outcomes and preventing complications at the American Society of Plastic Surgeons (ASPS) Plastic Surgery 2009 conference, Oct. 23-27, in Seattle.
By the Numbers:
In 2008, more than 3,500 buttock lifts and 853 buttock implant procedures were performed, reports the ASPS.
Buttock lifts are up 162 percent since 2000.
Panel: "Achieving Predictable Outcomes in Buttock Rejuvenation - Autoaugmentation vs. Fat Injections" was held Oct. 26 at the Washington State Convention and Trade Center.
Hospital Surgery Infection Rates Made Public
To contact us Click HERE
Washington State Hospital Association is releasing hospital-specific surgical infection rate data. This is the first time this information has been made public.
"Washington's hospitals are enthusiastic participants in providing this new information about surgical infection rates," said Carol Wagner, vice president for patient safety at the Washington State Hospital Association. "We believe that public reporting helps hospitals improve, assists consumers in making good decisions about hospital care, and creates collaboration between hospitals and quality experts."
The surgeries included in the new infection rate data are:
-- Heart bypass surgery;
-- Cardiac surgeries on the valves or septum of the heart;
-- Heart transplant surgery;
-- Knee replacement;
-- Hip replacement;
-- Abdominal hysterectomy; and
-- Vaginal hysterectomy.
The website allows users to sort hospitals by county, alphabetically, and from highest to lowest or lowest to highest infection rates.
Washington's hospitals use a series of scientifically proven safeguards against surgical infections and the new data helps hospitals evaluate the effectiveness of their processes. These processes include:
-- Ensuring the proper antibiotic is given at the correct time and stopped at the correct time;
-- Ensuring the patient's blood sugar is under control; and
-- Removing hair safely (not using a razor) in the surgical area.
Washington's hospitals are dedicated to stopping the spread of infections. Stopping infections is challenging work: today's hospital patients are sicker and more vulnerable, drug resistant organisms are increasing, and antibiotic overuse has hampered the ability to fight infections.
Hospital patients are an important part of their own care team and have a role to play in preventing infections. Things patients can do to protect themselves include:
-- Taking all the recommended pre-hospitalization infection prevention steps, such as pre-surgical chlorhexidine baths, not shaving before surgery, and stopping smoking;
-- Asking all health care providers and visitors to wash or sanitize their hands, especially when they enter or leave a patient's room;
-- Taking antibiotics and other medications exactly as directed by their doctor; and
-- Asking their visitors to stay home if they are sick.
"Hospitals are dedicated to the care and comfort of our patients. In most cases, the data show good results, though there are also areas for improvement. Our member hospitals are working hard to implement changes to stop surgical infections, and we expect the results to get better and better," concluded Wagner.
Washington State's infection reporting program is considered a national leader. The National Conference of State Legislatures highlighted Washington, along with nine other states, in its recent report, "Lessons from the Pioneers: Reporting Healthcare-Associated Infections."
"Washington's hospitals are enthusiastic participants in providing this new information about surgical infection rates," said Carol Wagner, vice president for patient safety at the Washington State Hospital Association. "We believe that public reporting helps hospitals improve, assists consumers in making good decisions about hospital care, and creates collaboration between hospitals and quality experts."
The surgeries included in the new infection rate data are:
-- Heart bypass surgery;
-- Cardiac surgeries on the valves or septum of the heart;
-- Heart transplant surgery;
-- Knee replacement;
-- Hip replacement;
-- Abdominal hysterectomy; and
-- Vaginal hysterectomy.
The website allows users to sort hospitals by county, alphabetically, and from highest to lowest or lowest to highest infection rates.
Washington's hospitals use a series of scientifically proven safeguards against surgical infections and the new data helps hospitals evaluate the effectiveness of their processes. These processes include:
-- Ensuring the proper antibiotic is given at the correct time and stopped at the correct time;
-- Ensuring the patient's blood sugar is under control; and
-- Removing hair safely (not using a razor) in the surgical area.
Washington's hospitals are dedicated to stopping the spread of infections. Stopping infections is challenging work: today's hospital patients are sicker and more vulnerable, drug resistant organisms are increasing, and antibiotic overuse has hampered the ability to fight infections.
Hospital patients are an important part of their own care team and have a role to play in preventing infections. Things patients can do to protect themselves include:
-- Taking all the recommended pre-hospitalization infection prevention steps, such as pre-surgical chlorhexidine baths, not shaving before surgery, and stopping smoking;
-- Asking all health care providers and visitors to wash or sanitize their hands, especially when they enter or leave a patient's room;
-- Taking antibiotics and other medications exactly as directed by their doctor; and
-- Asking their visitors to stay home if they are sick.
"Hospitals are dedicated to the care and comfort of our patients. In most cases, the data show good results, though there are also areas for improvement. Our member hospitals are working hard to implement changes to stop surgical infections, and we expect the results to get better and better," concluded Wagner.
Washington State's infection reporting program is considered a national leader. The National Conference of State Legislatures highlighted Washington, along with nine other states, in its recent report, "Lessons from the Pioneers: Reporting Healthcare-Associated Infections."
Skin Flaps Deliver Cancer Fighting Therapy, ASPS Study Reveals
To contact us Click HERE
Using gene
therapy, plastic surgeons have delivered cancer fighting proteins through
skin flaps placed on cancerous tumors on rats with a 79 percent reduction
in tumor volume, according to a study in the May issue of Plastic and
Reconstructive Surgery(R), the official medical journal of the American
Society of Plastic Surgeons (ASPS). This new delivery technique, which has
yet to be tested in humans, did not cause toxicity in the body of rats;
however, administering the same anti-tumor agent intravenously in humans
has previously been shown to cause liver damage.
"This new technique may allow us to reprogram skin flaps, using gene
therapy, to provide a blueprint for anti-tumor agents like Interleukin-12
to be produced in the tumor to kill cancer, while avoiding adverse side
effects," said Geoffrey Gurtner, MD, ASPS Member and study senior author.
"In this study we took skin flaps in animal models and delivered IL-12
directly to the tumor area with tremendous success. Since skin flaps are
used thousands of times each year in cancer patients, this may potentially
open up an entirely new area in plastic surgery and bring the specialty,
once again, to the center of medicine."
Gene therapy has been heralded as a new tool to restrain or prevent
tumor growth and recurrence in humans, but its use has been limited because
of serious side effects and the difficulty in concentrating anti-tumor
agents at the site of the cancer.
In the study, skin flaps (a mass of healthy tissue) taken from rats
were injected with the gene for IL-12 into the flaps' blood supply. The
flaps were then placed onto cancerous tumors on the rats.
The study found a 79 percent reduction in tumor volume for animals
treated with IL-12 compared to control animals. The treatment allowed
individual cells within the flap to become encoded with IL-12 and function
as "miniature factories" producing the IL-12 protein at very high levels in
the tumor site, according to the study.
Additionally, the serious side effects previously documented with
systemic use of IL-12 were not found in the treated rats. The liver, lung
and spleen remained normal throughout the study. The delivery technique
through free flaps did not cause liver toxicity, whereas using IL-12
intravenously in humans has been shown to cause liver damage.
"This could be a major advance for the delivery of a therapeutic agent
to diseased parts of the body," said Dr. Gurtner. "I can see this therapy
being used for breast cancer, head and neck cancers, central nervous system
malignancies, and somewhere down the line hemophilia, diabetes and
infections."
The study authors concluded that as oncologic reconstructive surgery is
a major component of plastic surgery, the delivery of a healing agent
precisely to the region where cancer was and where local recurrences are
most likely to occur, could add a new dimension to the reconstructive
function of free flaps in oncologic and reconstructive plastic surgery.
Nearly 5.2 million reconstructive plastic surgery procedures were
performed in 2007, according to ASPS statistics. More than 3.8 million
tumor removals and 57,000 breast reconstructions were performed last year.
Visit plasticsurgery for referrals to ASPS Member Surgeons and
to learn more about cosmetic and reconstructive plastic surgery.
The American Society of Plastic Surgeons is the largest organization of
board-certified plastic surgeons in the world. Representing more than 6,700
physician members, the Society is recognized as a leading authority and
information source on cosmetic and reconstructive plastic surgery. ASPS
comprises more than 90 percent of all board-certified plastic surgeons in
the United States. Founded in 1931, the Society represents physicians
certified by The American Board of Plastic Surgery or The Royal College of
Physicians and Surgeons of Canada.
American Society of Plastic Surgeons
plasticsurgery
therapy, plastic surgeons have delivered cancer fighting proteins through
skin flaps placed on cancerous tumors on rats with a 79 percent reduction
in tumor volume, according to a study in the May issue of Plastic and
Reconstructive Surgery(R), the official medical journal of the American
Society of Plastic Surgeons (ASPS). This new delivery technique, which has
yet to be tested in humans, did not cause toxicity in the body of rats;
however, administering the same anti-tumor agent intravenously in humans
has previously been shown to cause liver damage.
"This new technique may allow us to reprogram skin flaps, using gene
therapy, to provide a blueprint for anti-tumor agents like Interleukin-12
to be produced in the tumor to kill cancer, while avoiding adverse side
effects," said Geoffrey Gurtner, MD, ASPS Member and study senior author.
"In this study we took skin flaps in animal models and delivered IL-12
directly to the tumor area with tremendous success. Since skin flaps are
used thousands of times each year in cancer patients, this may potentially
open up an entirely new area in plastic surgery and bring the specialty,
once again, to the center of medicine."
Gene therapy has been heralded as a new tool to restrain or prevent
tumor growth and recurrence in humans, but its use has been limited because
of serious side effects and the difficulty in concentrating anti-tumor
agents at the site of the cancer.
In the study, skin flaps (a mass of healthy tissue) taken from rats
were injected with the gene for IL-12 into the flaps' blood supply. The
flaps were then placed onto cancerous tumors on the rats.
The study found a 79 percent reduction in tumor volume for animals
treated with IL-12 compared to control animals. The treatment allowed
individual cells within the flap to become encoded with IL-12 and function
as "miniature factories" producing the IL-12 protein at very high levels in
the tumor site, according to the study.
Additionally, the serious side effects previously documented with
systemic use of IL-12 were not found in the treated rats. The liver, lung
and spleen remained normal throughout the study. The delivery technique
through free flaps did not cause liver toxicity, whereas using IL-12
intravenously in humans has been shown to cause liver damage.
"This could be a major advance for the delivery of a therapeutic agent
to diseased parts of the body," said Dr. Gurtner. "I can see this therapy
being used for breast cancer, head and neck cancers, central nervous system
malignancies, and somewhere down the line hemophilia, diabetes and
infections."
The study authors concluded that as oncologic reconstructive surgery is
a major component of plastic surgery, the delivery of a healing agent
precisely to the region where cancer was and where local recurrences are
most likely to occur, could add a new dimension to the reconstructive
function of free flaps in oncologic and reconstructive plastic surgery.
Nearly 5.2 million reconstructive plastic surgery procedures were
performed in 2007, according to ASPS statistics. More than 3.8 million
tumor removals and 57,000 breast reconstructions were performed last year.
Visit plasticsurgery for referrals to ASPS Member Surgeons and
to learn more about cosmetic and reconstructive plastic surgery.
The American Society of Plastic Surgeons is the largest organization of
board-certified plastic surgeons in the world. Representing more than 6,700
physician members, the Society is recognized as a leading authority and
information source on cosmetic and reconstructive plastic surgery. ASPS
comprises more than 90 percent of all board-certified plastic surgeons in
the United States. Founded in 1931, the Society represents physicians
certified by The American Board of Plastic Surgery or The Royal College of
Physicians and Surgeons of Canada.
American Society of Plastic Surgeons
plasticsurgery
Subscribe to:
Comments (Atom)